Colgate-Palmolive (NYSE:CL) Stock Holdings Lessened by Carret Asset Management LLC

Carret Asset Management LLC reduced its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 0.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 16,214 shares of the company’s stock after selling 124 shares during the period. Carret Asset Management LLC’s holdings in Colgate-Palmolive were worth $1,292,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the company. &PARTNERS boosted its stake in Colgate-Palmolive by 0.7% during the fourth quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after acquiring an additional 129 shares in the last quarter. West Branch Capital LLC increased its holdings in Colgate-Palmolive by 24.0% during the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after buying an additional 132 shares during the last quarter. First Foundation Advisors increased its holdings in Colgate-Palmolive by 2.7% during the third quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock worth $372,000 after buying an additional 136 shares during the last quarter. Waldron Private Wealth LLC increased its holdings in Colgate-Palmolive by 2.7% during the third quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock worth $381,000 after buying an additional 140 shares during the last quarter. Finally, Autumn Glory Partners LLC increased its stake in shares of Colgate-Palmolive by 2.7% in the fourth quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock worth $424,000 after purchasing an additional 140 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on CL shares. Wells Fargo & Company raised their price objective on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the company an “equal weight” rating in a research report on Monday, January 29th. Citigroup lifted their target price on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, April 16th. Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective for the company in a report on Monday, January 29th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Finally, The Goldman Sachs Group assumed coverage on shares of Colgate-Palmolive in a research report on Friday, March 1st. They issued a “buy” rating and a $93.00 target price on the stock. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $89.50.

Check Out Our Latest Stock Analysis on CL

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the sale, the insider now directly owns 59,698 shares in the company, valued at approximately $5,054,629.66. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock valued at $19,505,099 in the last quarter. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Up 0.5 %

Shares of NYSE CL traded up $0.43 during mid-day trading on Thursday, reaching $89.30. 2,356,538 shares of the company’s stock were exchanged, compared to its average volume of 4,520,912. The firm has a market capitalization of $73.40 billion, a price-to-earnings ratio of 31.97, a PEG ratio of 3.33 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. Colgate-Palmolive has a 52-week low of $67.62 and a 52-week high of $90.37. The company’s 50-day moving average is $87.40 and its 200-day moving average is $81.25.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The company had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $4.89 billion. During the same period last year, the business posted $0.77 EPS. Colgate-Palmolive’s revenue for the quarter was up 6.9% on a year-over-year basis. Analysts expect that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a $0.50 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.24%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 71.94%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.